Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.
Mazeron MC, Fillet AM, Salmon D, Boukli N, Houhou N, Sénéchal B, Matheron S, Gozlan J, Leport C, Katlama C, Scieux C, Imbert BM, Deny P, Bour JB, Freymuth F, Chanzy B, Chaput S, Costagliola D; Predivir Study Group.
Mazeron MC, et al. Among authors: katlama c.
AIDS. 2003 Mar 28;17(5):784-6. doi: 10.1097/00002030-200303280-00029.
AIDS. 2003.
PMID: 12646814
No abstract available.